Preventing adverse reactions in pediatric transfusions using washed platelet concentrate

Area of Science:

• Pediatric Hematology
• Transfusion Medicine
• Immunology

Background:

• Transfusion-associated adverse reactions (TARs) are a significant concern in pediatric supportive care.
• Allergic transfusion reactions (ATRs) and febrile non-hemolytic transfusion reactions (FNHTRs) are common TARs, particularly with platelet concentrate (PC).
• Plasma components in blood products are implicated in TARs, with patient factors like age and disease also playing a role.

Purpose of the Study:

• To evaluate the effectiveness of washed platelet concentrate (PC) in preventing TARs in pediatric patients.
• To assess the impact of novel platelet additive solutions on platelet quality and transfusion outcomes.
• To determine if washed PC can prevent ATRs and FNHTRs without compromising therapeutic effects.

Main Methods:

• Review of clinical use and efficacy of washed PC in pediatric patients in Japan.
• Utilized platelet additive solutions like M-sol and BRS-A for storage of washed PC.
• Compared outcomes of washed PC transfusions with conventional PC preparations.

Main Results:

• Washed PC effectively prevents ATRs and FNHTRs in pediatric patients.
• New additive solutions (M-sol, BRS-A) maintain platelet quality during extended storage.
• Washed PC provides effective transfusion support without diminishing therapeutic benefits.

Conclusions:

• Washed PC, especially when prepared with M-sol or BRS-A, is a safe and effective strategy for preventing TARs in children.
• The widespread availability of washed PC in Japan enhances pediatric transfusion safety.
• This approach offers a significant advancement in managing transfusion reactions in pediatric care.